Medtronic's Diabetes Spinoff Just Surged. What To Look For In Its Earnings.

Medtronic (MDT) stock popped Tuesday as its diabetes spinoff Minimed (MMED) rallied, reversing premarket losses, after both lifted their full-year guidance. Medtronic posted organic sales growth of 13.7%, roughly 200 basis points above the midpoint of its guidance, Evercore ISI analyst Vijay Kumar said in a report. Importantly, cardiovascular and medical-surgical sales all topped forecasts, but neuroscience coming in line.…